| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $20,267,061 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01CA299966 | A Randomized Controlled Trial On Improving Prostate Cancer Screening Among Black Men in Oklahoma Using A Community-Based mHealth Approach (Prostate Cancer Genius App) | 000 | 1 | NIH | 5/19/2026 | $592,731 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01MH125998 | Regulation of Oxytocin Receptor Signaling in Neurons | 000 | 5 | NIH | 5/19/2026 | $362,500 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | K01AG087810 | Tracking myeloid heterogeneity in mouse models and cerebrospinal fluid of HIV-suppressed individuals to classify neuroinflammation and identify molecular markers associated with clinical pathology | 000 | 3 | NIH | 5/18/2026 | $131,922 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 560 | Oklahoma City | OK | 73104-3650 | OKLAHOMA | USA | T3555310 | Primary Care Training and Enhancement -- Residency Training in Street Medicine | 00 | 2 | HRSA | 5/14/2026 | $500,000 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HL161008 | Biomarker-guided optimization of transcutaneous vagal stimulation for atrial fibrillation | 000 | 5 | NIH | 3/3/2026 | $379,891 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9952111 | Value-Based Medical Student Education Training Program | 03 | 3 | HRSA | 2/23/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9952111 | Value-Based Medical Student Education Training Program | 03 | 3 | HRSA | 2/23/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9952111 | Value-Based Medical Student Education Training Program | 03 | 3 | HRSA | 2/23/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9952111 | Value-Based Medical Student Education Training Program | 03 | 3 | HRSA | 2/23/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R00GM141267 | Identification of novel osmosensing receptors in C. elegans | 000 | 5 | NIH | 1/9/2026 | $224,100 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HD109784 | Prevention of Necrotizing Enterocolitis | 000 | 4 | NIH | 1/14/2026 | $368,415 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA297076 | Protein-nanoparticle interaction to study multicellular crosstalk within ovarian tumor microenviroment | 000 | 2 | NIH | 1/19/2026 | $293,492 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK133207 | ROCK, tight junctions and prematurity in the pathogenesis of necrotizing enterocolitis and neonatal sepsis. | 000 | 4 | NIH | 1/19/2026 | $480,675 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K08HL177251 | Gene Regulatory Mechanisms of the Coronary Artery Disease Gene PRDM16 on Smooth Muscle Cell Phenotypic Modulation | 001 | 2 | NIH | 2/20/2026 | $145,044 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | F30NS143384 | Determining the Role of Mitochondrial Hydrogen Peroxide in the Regulation of Neuronal Mitochondrial Networks | 001 | 1 | NIH | 2/17/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31DK146691 | Role of interferon gamma in injury accelerated cystic kidney disease | 000 | 1 | NIH | 12/19/2025 | $41,422 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA298165 | A Randomized Factorial Trial of Varenicline with Nicotine Lozenges and a Smartphone Medication Adherence Intervention to Promote Smoking Cessation | 000 | 2 | NIH | 12/17/2025 | $546,679 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F30NS143384 | Determining the Role of Mitochondrial Hydrogen Peroxide in the Regulation of Neuronal Mitochondrial Networks | 000 | 1 | NIH | 2/17/2026 | $38,666 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9952111 | Value-Based Medical Student Education Training Program | 01 | 3 | HRSA | 12/9/2025 | $255,758 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9952111 | Value-Based Medical Student Education Training Program | 01 | 3 | HRSA | 12/9/2025 | $11,973 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9952111 | Value-Based Medical Student Education Training Program | 01 | 3 | HRSA | 12/9/2025 | $857,988 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9952111 | Value-Based Medical Student Education Training Program | 01 | 3 | HRSA | 12/9/2025 | $49,281 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 00 | 30 | HRSA | 12/29/2025 | $293,192 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H3306689 | EMSC Partnership Grants | 00 | 21 | HRSA | 4/10/2026 | $67,427 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K01DA055073 | Identifying and Addressing the Effects of Social Media Use on Young Adults' E-Cigarette Use: A Solutions-Oriented Approach | 000 | 4 | NIH | 2/10/2026 | $198,612 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA260449 | Exploiting gold nanoparticle as a probe to identify therapeutic targets | 000 | 5 | NIH | 12/4/2025 | $319,463 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U01DK135007 | Identifying Metabolic and Psychosocial Antecedents and Characteristics of youth-onset Type 2 diabetes (IMPACT DM) | 000 | 4 | NIH | 2/10/2026 | $825,450 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK139443 | Evaluating PQQ for preventing maternal obesity-induced fetal programming of juvenile NAFLD in Papio anubis | 000 | 3 | NIH | 2/10/2026 | $602,977 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | F31AI197827 | Investigating the role of T cell-derived acetylcholine during Influenza A Virus infection | 000 | 1 | NIH | 4/27/2026 | $47,914 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01EY028608 | Caveolae-Based Mechanosensors for Conventional Outflow Regulation | 000 | 7 | NIH | 4/28/2026 | $604,777 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01DK117965 | Regulation of Bile Acid Metabolism and Signaling in Metabolic Diseases | 000 | 7 | NIH | 4/28/2026 | $557,341 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01AI185203 | Targeting chondroitin sulfate proteoglycan 4 (CSPG4) expression as a Clostridioides difficile therapeutic | 000 | 3 | NIH | 4/24/2026 | $357,500 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | F31DK146691 | Role of interferon gamma in injury accelerated cystic kidney disease | 002 | 1 | NIH | 4/10/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01HL169530 | Mechanism of F-18-fluorodeoxyglucarate accrual in myocardial injury | 000 | 3 | NIH | 4/28/2026 | $362,500 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01EY033499 | Targeting Surfactant Protein A to Prevent Retinopathy of Prematurity | 000 | 3 | NIH | 5/4/2026 | $471,607 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01CA163649 | Targeting Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer | 001 | 11 | NIH | 4/29/2026 | $478,274 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | P20GM161969 | Oklahoma Center for Biomedical Research Excellence in Sensory Biology | 000 | 1 | NIH | 5/5/2026 | $2,129,950 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01DK147452 | Defining the role of Polycystin 1 as a G protein coupled receptor in kidney cystogenesis | 000 | 1 | NIH | 4/21/2026 | $620,185 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R03CA301367 | Evaluating inherited genetic variation and outcome among children andadolescents treated for acute myeloid leukemia | 000 | 1 | NIH | 4/21/2026 | $318,411 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | F32DK146538 | Developmental Programming of Mitochondrial Function and Pediatric MASLD | 000 | 1 | NIH | 5/5/2026 | $79,068 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | UG3CA290310 | Discovery and Development of Natural Products for Interception of CRC | 001 | 3 | NIH | 4/27/2026 | $303,875 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | K01DA063913 | Integrating Peer Mentoring Into Social Media-Based Vaping Cessation Interventions for Young Adults | 000 | 1 | NIH | 5/1/2026 | $200,951 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01HD110585 | Preconception Maternal Nutrition, Offspring DNA Methylation, and InfantGrowth in Low Resource Settings | 001 | 3 | NIH | 4/23/2026 | $46,775 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9952111 | Value-Based Medical Student Education Training Program | 04 | 3 | HRSA | 3/23/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9952111 | Value-Based Medical Student Education Training Program | 04 | 3 | HRSA | 3/23/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9952111 | Value-Based Medical Student Education Training Program | 04 | 3 | HRSA | 3/23/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9952111 | Value-Based Medical Student Education Training Program | 04 | 3 | HRSA | 3/23/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | F31AI189149 | Human gut Bacteroidales defense mechanisms against emerging antibacterial toxins | 001 | 2 | NIH | 4/20/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01DA060878 | Using Real Time Data to Examine the Impact of Product Characteristics on Young Adult ENDS Use | 000 | 2 | NIH | 5/12/2026 | $673,437 |
|
